Frédérique Penault‐Llorca

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli et al. · Nature Medicine · 2014 · 1K citations

Medicine, Cancer Biology, Oncology +12

Analysis of <i>PTEN</i> , <i>BRAF</i> , and <i>EGFR</i> Status in Determining Benefit From Cetuximab Therapy in Wild-Type <i>KRAS</i> Metastatic Colon Cancer

Pierre Laurent‐Puig, Anne Cayre, Gilles Manceau et al. · Journal of Clinical Oncology · 2009 · 665 citations

Medicine, Oncology, Pharmacology +17

Amphiregulin and Epiregulin mRNA Expression in Primary Tumors Predicts Outcome in Metastatic Colorectal Cancer Treated With Cetuximab

Bart Jacobs, Wendy De Roock, Hubert Piessevaux et al. · Journal of Clinical Oncology · 2009 · 368 citations · Full text

Medicine, Oncology, Pharmacology +17

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

Marjolaine Ngollo, Marine Daures, Gaëlle Judes et al. · BMC Cancer · 2017 · 112 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Interleukin-6 overexpression as a marker of malignancy in human gliomas

Christine Rolhion, Frédérique Penault‐Llorca, Jean-Louis Kémény et al. · Journal of neurosurgery · 2001 · 106 citations

Medicine, Immunology, Oncology +17